Fact CheckerSign in

NCT06143839Completed

VYxeoS Liposomal Italian Observational Study iN the Real Practice

Source: ClinicalTrials.gov · Last updated 20 Nov 2025

Brief summary (registry, in English)

The study is a prospective, single-arm, non-experimental, observational study in patients in Italy with Acute Myeloid Leukaemia (AML) with myelodysplastic-related changes or therapy related AML initiating treatment with JZP351 (Vyxeos liposomal) in their normal clinical practice.

Status (registry)
Completed
Study type
Observational
Enrollment
113 (actual)
First submitted
16 Nov 2023
Start date
7 Dec 2023
Primary completion date
23 Oct 2025
Lead sponsor
Jazz Pharmaceuticals
NCT number
NCT06143839

What you commit to

  • Study type: Observational
  • Participants enrolled: 113
  • From 7 Dec 2023 to the primary completion date, 23 Oct 2025
  • 24 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior treatment intended for induction therapy of AML (Acute Myeloid Leukemia).
  • Patients with prior cumulative anthracycline exposure of greater than 368 mg/m2 daunorubicin (or equivalent)

Other illness

  • Patients with active (uncontrolled, metastatic) second malignancies.

Other

  • Clinical evidence of active CNS (Central Nervous System) leukemia.

Who the study is looking for

  • Patients newly diagnosed with AML-MRC (Acute myeloid leukemia with myelodysplasia-related changes) or t-related AML (Therapy related Acute myeloid leukemia) following 2016 World Health Organization (WHO) classification.
  • Age ≥ 18 years old.
  • Patients considered eligible for intensive chemotherapy in the opinion of the treating physician.
  • Patients who will initiate the treatment with commercially JZP351 treatment after the Informed Consent Form (ICF) signature. The decision to prescribe JZP351 treatment must have been made prior and regardless of the enrollment of the patient in the study.
  • Cardiac ejection fraction ≥ 50% by echocardiography or MUGA (Multi-Gated Acquisition).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (24)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo
Coordinator of this site? Confirm its status
AlessandriaItalyUnknown status
Ospedale Papa Giovanni XXIII
Coordinator of this site? Confirm its status
BergamoItalyUnknown status
Policlinico Sant'Orsola
Coordinator of this site? Confirm its status
BolognaItalyUnknown status
Ospedale di Bolzano
Coordinator of this site? Confirm its status
BolzanoItalyUnknown status
Ospedale Busto Arsizio
Coordinator of this site? Confirm its status
Busto ArsizioItalyUnknown status
Istituto Oncologico Veneto
Coordinator of this site? Confirm its status
Castelfranco VenetoItalyUnknown status
Ospedale Careggi
Coordinator of this site? Confirm its status
FlorenceItalyUnknown status
Policlinico San Martino
Coordinator of this site? Confirm its status
GenovaItalyUnknown status
Ospedale Vito Fazzi
Coordinator of this site? Confirm its status
LecceItalyUnknown status
Policlinico di Milano Ospedale Maggiore
Coordinator of this site? Confirm its status
MilanItalyUnknown status
Azienda Ospedaliera Universitaria Federico II
Coordinator of this site? Confirm its status
NaplesItalyUnknown status
Ospedale Cardarelli
Coordinator of this site? Confirm its status
NaplesItalyUnknown status
Ospedali Riuniti Villa Sofia - Cervello
Coordinator of this site? Confirm its status
PalermoItalyUnknown status
Ospedale Civile Santo Spirito
Coordinator of this site? Confirm its status
PescaraItalyUnknown status
Ospedale Santa Chiara
Coordinator of this site? Confirm its status
PisaItalyUnknown status
Ospedale di Ravenna
Coordinator of this site? Confirm its status
RavennaItalyUnknown status
Ospedale Bianchi Melacrino Morelli
Coordinator of this site? Confirm its status
Reggio CalabriaItalyUnknown status
Policlinico Agostino Gemelli
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Ospedale Sant'Eugenio
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Policlinico Umberto I
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Policlinico Tor Vergata
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Policlinico Molinette
Coordinator of this site? Confirm its status
TorinoItalyUnknown status
Ospedale Riuniti Marche Nord
Coordinator of this site? Confirm its status
Torrette AnconaItalyUnknown status
Ospedale di Trieste
Coordinator of this site? Confirm its status
TriesteItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.